课题基金 / 基金详情

Enzyme-based approach to probe the specificity of heparanase and its inhibitor

Enzyme-based approach to probe the specificity of heparanase and its inhibitor
基于酶的方法探测乙酰肝素酶及其抑制剂的特异性
批准号:
7808617
负责人:
Sherket Breshon Peterson
金额:
$3.22万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-02-01 至 2013-01-31

项目摘要

项目成果

Sherket Breshon Peterson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):细胞外基质的各种成分的降解,包括硫酸肝素蛋白聚糖,是癌症侵袭和转移过程中的关键步骤。肝素酶是一种降解HS的内切p- d -糖苷酶,由于其促转移、促炎症和促血管生成的活性,已成为抗癌治疗的一个有希望的靶点。因此,我们寻求利用一种新的酶法来探测肝素酶及其抑制剂的特异性。
英文摘要
DESCRIPTION (provided by applicant): The degradation of various constituents of the extracellular matrix including, heparan sulfate proteoglycans, represents a critical step in the process of cancer invasion and metastasis. Heparanase, an endo-p-D- glycosidase which degrades HS, has emerged as a promising target for the development of anti-cancer treatment because of its pro-metastatic, pro-inflammatory, and pro-angiogenic activity. Therefore we sought to utilize a novel enzymatic approach to probe the specificity of heparanase and its inhibitor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of O-GlcNAcylation in Diabetic Nephropathy
  • 批准号:
    8909268
  • 项目类别:
  • 资助金额:
    $5.42万
  • 财政年份:
    2015
  • 负责人:
    Sherket Breshon Peterson
  • 依托单位:
Enzyme-based approach to probe the specificity of heparanase and its inhibitor
  • 批准号:
    8034361
  • 项目类别:
  • 资助金额:
    $3.27万
  • 财政年份:
    2010
  • 负责人:
    Sherket Breshon Peterson
  • 依托单位:
Enzyme-based approach to probe the specificity of heparanase and its inhibitor
  • 批准号:
    8212255
  • 项目类别:
  • 资助金额:
    $2.39万
  • 财政年份:
    2010
  • 负责人:
    Sherket Breshon Peterson
  • 依托单位:
海外基金